focus -WSS

focus

author：knowledge 2025-09-14 18:29:46 - browse：9

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for the last day here.

ASCO is more than half done. There is free coffee on the exhibit floor. One booth barista said their team had made 1,400 espressos in a day. Everyone’s perspective is alternating between two verses from Smashing Pumpkins, who are, lest you forget, a Chicago band. “Today is the greatest day I’ve ever known.” Also: “I’ll burn my eyes out before I get out.”

What if sometimes cancer doctors could give less medicine?

Are cancer drugs more likely to be cures? Or could they instead turn cancer into a chronic disease, in which medicines keep tumors in check but patients have to deal with their side effects, both physical and financial, for the rest of their lives.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

focus

WSS

Obesity drugs seen as possible treatment for liver disease MASH

How a key Senate committee is planning to regulate PBMs

Obesity drugs seen as possible treatment for liver disease MASH

Statins reduce cardiovascular risk in people living with HIV

Statins reduce cardiovascular risk in people living with HIV

New documents shed light on MD Anderson Cancer Institute feud

knowledge

focus

What if sometimes cancer doctors could give less medicine?

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Duchenne breakthrough therapy leaves behind pioneering families

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

In age of alternative facts, a scholarly course on calling out crap

Burning questions about Delta and the next phase of the Covid pandemic

Moonlake's readout produced a cash windfall. Risks remain

Severe heat forecast: Where scorching temperatures will persist over the next week

Walensky prepares to leave CDC — and Congress — behind

6 phony surgeries that take placebo to the extreme

Moonlake's readout produced a cash windfall. Risks remain

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

hotspot

How to protect coverage of PrEP

Alabama frozen embryo ruling has major implications for IVF clinics

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Drone hits Crimean ammunition depot as strikes kill, wound civilians and journalists in Ukraine

Alabama frozen embryo ruling has major implications for IVF clinics

hotspot

leisure time

focus

explore